Insulin Resistance and Metabolic Syndrome

Insulin resistance lies at the core of metabolic syndrome, a cluster of metabolic abnormalities including central obesity, dyslipidemia, hypertension, and impaired glucose metabolism. Insulin resistance disrupts cellular signaling pathways, leading to metabolic dysregulation and increased cardiovascular risk. Mechanisms linking insulin resistance to metabolic syndrome involve adipose tissue dysfunction, chronic low-grade inflammation, and mitochondrial dysfunction. Lifestyle interventions targeting insulin sensitivity through dietary modifications and exercise can mitigate metabolic syndrome components and reduce cardiovascular risk. Pharmacotherapeutic approaches also aim to improve insulin sensitivity and address individual components of metabolic syndrome, emphasizing personalized management strategies in high-risk individuals.

    Related Conference of Insulin Resistance and Metabolic Syndrome

    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 09-10, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK

    Insulin Resistance and Metabolic Syndrome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in